Jim Simons Medpace Holdings, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 678,088 shares of MEDP stock, worth $338 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

678,088

Previous 577,688 17.38%

Holding current value

$338 Million

Previous $176 Million 20.91%

% of portfolio

0.3%

Previous 0.28%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$277.23 - $315.28 $27.8 Million - $31.7 Million	100,400 Added 17.38%	678,088 $213 Million
Q1 2025 May 14, 2025	BUY	$304.69 - $360.97 $7.34 Million - $8.7 Million	24,100 Added 4.35%	577,688 $176 Million
Q4 2024 Feb 13, 2025	BUY	$308.93 - $363.58 $18.9 Million - $22.2 Million	61,100 Added 12.41%	553,588 $184 Million
Q3 2024 Nov 13, 2024	BUY	$320.58 - $457.29 $15.7 Million - $22.4 Million	48,900 Added 11.02%	492,488 $164 Million
Q2 2024 Aug 09, 2024	BUY	$372.0 - $424.34 $45.7 Million - $52.1 Million	122,800 Added 38.28%	443,588 $183 Million
Q1 2024 May 13, 2024	BUY	$284.87 - $413.31 $19.8 Million - $28.7 Million	69,400 Added 27.61%	320,788 $130 Million
Q4 2023 Feb 13, 2024	SELL	$227.52 - $312.68 $1.77 Million - $2.44 Million	-7,800 Reduced 3.01%	251,388 $77.1 Million
Q3 2023 Nov 14, 2023	BUY	$233.98 - $281.67 $11.3 Million - $13.6 Million	48,300 Added 22.9%	259,188 $62.8 Million
Q2 2023 Aug 11, 2023	SELL	$187.26 - $240.17 $16.2 Million - $20.8 Million	-86,600 Reduced 29.11%	210,888 $50.6 Million
Q1 2023 May 12, 2023	BUY	$174.31 - $239.52 $16.3 Million - $22.4 Million	93,500 Added 45.84%	297,488 $55.9 Million
Q4 2022 Feb 13, 2023	SELL	$153.06 - $226.57 $9.52 Million - $14.1 Million	-62,200 Reduced 23.37%	203,988 $43.3 Million
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $12.9 Million - $16.2 Million	-88,700 Reduced 24.99%	266,188 $41.8 Million
Q2 2022 Aug 12, 2022	SELL	$130.2 - $168.03 $3.28 Million - $4.23 Million	-25,200 Reduced 6.63%	354,888 $53.1 Million
Q1 2022 May 13, 2022	SELL	$138.87 - $214.31 $2.06 Million - $3.17 Million	-14,800 Reduced 3.75%	380,088 $62.2 Million
Q4 2021 Feb 11, 2022	SELL	$182.74 - $227.9 $3.47 Million - $4.33 Million	-19,000 Reduced 4.59%	394,888 $85.9 Million
Q3 2021 Nov 12, 2021	SELL	$170.18 - $198.21 $1.43 Million - $1.66 Million	-8,400 Reduced 1.99%	413,888 $78.3 Million
Q2 2021 Aug 13, 2021	SELL	$158.62 - $194.3 $6.68 Million - $8.18 Million	-42,100 Reduced 9.07%	422,288 $74.6 Million
Q1 2021 May 13, 2021	SELL	$132.02 - $168.26 $18.4 Million - $23.5 Million	-139,400 Reduced 23.09%	464,388 $76.2 Million
Q4 2020 Feb 10, 2021	SELL	$109.38 - $149.19 $25.6 Million - $35 Million	-234,300 Reduced 27.96%	603,788 $84 Million
Q3 2020 Nov 13, 2020	SELL	$92.95 - $130.61 $3.28 Million - $4.61 Million	-35,332 Reduced 4.05%	838,088 $93.7 Million
Q2 2020 Aug 13, 2020	BUY	$68.08 - $95.68 $3.66 Million - $5.14 Million	53,732 Added 6.56%	873,420 $81.2 Million
Q1 2020 May 14, 2020	BUY	$61.71 - $101.95 $14.4 Million - $23.8 Million	233,600 Added 39.86%	819,688 $60.1 Million
Q4 2019 Feb 13, 2020	BUY	$70.08 - $84.64 $7.86 Million - $9.49 Million	112,100 Added 23.65%	586,088 $49.3 Million
Q3 2019 Nov 13, 2019	BUY	$62.38 - $85.89 $8.16 Million - $11.2 Million	130,888 Added 38.15%	473,988 $39.8 Million
Q2 2019 Aug 12, 2019	BUY	$53.64 - $65.42 $5.42 Million - $6.61 Million	101,000 Added 41.72%	343,100 $22.4 Million
Q1 2019 May 14, 2019	SELL	$49.38 - $70.58 $12.2 Million - $17.4 Million	-246,400 Reduced 50.44%	242,100 $14.3 Million
Q4 2018 Feb 13, 2019	BUY	$46.97 - $63.98 $22.9 Million - $31.3 Million	488,500 New	488,500 $25.9 Million

Others Institutions Holding MEDP

# of Institutions

649

Shares Held

26.9M

Call Options Held

54.2K

Put Options Held

108K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $15.5B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account